Leveraging Agile Solutions for New Modality ADC Manufacturing Challenges - 17th World ADC San Diego

Your Flagship Event Driving ADC Innovation, Insights & Connections

Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation
Iza-Bren Is Approved in China for Recurrent/Metastatic Nasopharyngeal Carcinoma
Novartis to acquire Myricx Bio for up to $1.5B, adding cancer-fighting ADC payload platform
Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
J&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio

Leveraging Agile Solutions for New Modality ADC Manufacturing Challenges

10:30 am - Monday 12th October 2026

Working through case studies demonstrating increased needs for high purity payloads
Evaluating efficient dual payload clearance for ADC DS at both R&D and manufacturing scale
Overcoming ADC regulatory challenges for microbial and cross-contamination compliance using multi-purpose vessels

Speakers:

Melanie Derde

Melanie Derde

Head of bioconjugation operations

Axplora

Florence LEIRIS

Florence LEIRIS

Head of R&D

Axplora